Seroquel Side Effects Sudden Cardiac Death Lawsuits
Seroquel Side Effects May Be Linked To Cardiac Death. The lawyers / attorneys at our firm are investigating the association between Seroquel and sudden cardiac deaths. At this time, we are offering free lawsuit consultations to the families of Seroquel sudden cardiac death victims. According to the American Heart Association, … [Read more...]
Avandia Most Adverse Event Report
Avandia, Seroquel Adverse Events. Avandia’s cardiovascular problems have long been the subject of concern and controversy. Now, reports FiercePharma, an adverse event (AE) report for last year’s third quarter indicated that GlaxoSmithKline’s Avandia (generic: rosiglitazone) was number one on the list. The Institute for Safe … [Read more...]
More Worries Over Zyprexa, Seroquel, Other Antipsychotics
Antipsychotics Adverse Health Reactions. More Worries Over Some antipsychotic medications, including Zyprexa and Seroquel, have been linked to a variety of adverse health reactions including weight gain, hyperglycemia, and hyperlipidemia. Science Daily reports that the current issue of the journal Biological Psychiatry, … [Read more...]
Seroquel Maker Discussed Promoting Off-Label Uses
Makers Of Seroquel Promote Off Label Uses. Lawyers for people suing Seroquel maker AstraZeneca will charge today that executives at the company discussed promoting the off-label use of the drug in children and elderly patients. Immediate demand Seroquel - which was introduced in 1997 - is approved to treat psychotic disorders, … [Read more...]
FDA Panel Rejects Seroquel As Depression Treatment
Seroquel As First-Line Depression Treatment. Last week, the U.S. Food and Drug Administration (FDA) announced that while AstraZeneca’s schizophrenia and bipolar disorder medication, Seroquel (quetiapine), can be taken to treat depression, there are side effect concerns that include the risk of a sudden cardiac death, … [Read more...]
Buried Seroquel Study Detailed
Seroquel Study Buried By AstraZeneca. A Seroquel study completed the same year the drug was approved was apparently buried by AstraZeneca because of its disappointing results. According to The Washington Post, Seroquel Study 15 found that patients gained 11 pounds a year on the drug, something that would have put them at an increased … [Read more...]
Seroquel Victim Wants More AstraZeneca Documents Unsealed
AstraZeneca Documents Unsealed. A plaintiff in a Seroquel lawsuit is trying to convince a judge to unseal more AstraZeneca documents before a Food & Drug Administration (FDA) advisory panel meets next month to consider expanding the use of an extended-release version of the drug. The plaintiff blames Seroquel for his diabetes, … [Read more...]
More Seroquel Documents Unsealed
Seroquel Documents Unsealed. Unsealed documents have revealed that the antipsychotic drug Seroquel may not be as effective as older drugs. According to a report in The Wall Street Journal, the documents show that AstraZeneca produced an analysis of studies that found Seroquel to be less effective than one of the medications it was … [Read more...]
Antipsychotic Drugs in Nursing Homes
Antipsychotic Drugs Black Box Warning. Use of antipsychotic drugs like Risperdal and Seroquel to control dementia patients has risen in recent years, despite the Food and Drug Administration's (FDA) "black box" warning labels that these drugs can increase the risk of death for elderly dementia sufferers. About 30% of … [Read more...]
Seniors Face Risks with All Antipsychotic Drugs
Risks with All Antipsychotic Drugs. For the last couple of years, there have been a lot of questions raised about the cost, effectiveness, and safety of second-generation (or atypical) antipsychotic drugs such as Zyprexa, Seroquel, and Risperdal. However, a new Canadian study has found that older, conventional antipsychotic … [Read more...]
AstraZeneca Change Seroquel Promotions
AstraZeneca Cooperate With The FDA to Address The Concern About the Marketing Material of Seroquel. AstraZeneca Plc. said today it is cooperating with the Food and Drug Administration to address the agency's concern about marketing material the company distributed to physicians regarding Seroquel, its drug for treating … [Read more...]
AstraZeneca Misleading Seroquel Marketing Material
FDA Warned The Makers Of AstraZeneca For False Information. The U.S. Food and Drug Administration has sent a warning letter to drug maker AstraZeneca, claiming that some of the company’s promotional material for Seroquel contains “false or misleading” information. According to the FDA, AstraZeneca failed to adequately detail the … [Read more...]
FLA. COURT ASKED TO RECONSIDER SEROQUEL CLASS DENIAL
Plaintiffs In A Suit Involves Seroquel. Zehel-Miller v. AstraZeneca Pharms. Arguing that the court made "conclusory findings" in rejecting their class certification request, the plaintiffs in a suit involving the popular anti-psychotic Seroquel have asked a federal judge in Florida to reconsider the motion. Zehel-Miller et … [Read more...]
